BioMarin Pharmaceutical Inc. (BMRN): Share Price, Stock Analysis, Annual Report | Value Research Get BioMarin Pharmaceutical Inc. (BMRN)'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house.
info-circle
company-logo

Click to see a quick summary and important updates about this stock!Dismiss

  • Healthcare
  • Biotechnology & Pharma Research

BioMarin Pharmaceutical Inc. (BMRN)

NASDAQ: BMRN

  • Market Capitalisation info

    $17,633 Mln


  • 12 Month Earnings info

    $54 Mln

  • Price to Earnings info

    339.54

$95.07

As on 12-Aug-2022 16:00 EDT

$0.000.00%

  • Prev Close info

    $95.07

  • Day's Openinfo

    $94.75

  • Today's Highinfo

    $95.41

  • Today's Lowinfo

    $94.14

  • Today's Volumeinfo

    902,013

Please wait...

Stock Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
BioMarin Pharmaceutical (BMRN)
7.61 8.24 25.62 25.55 7.28 2.90 9.72
S&P BSE Sensex
2.08 9.32 9.94 9.05 16.53 13.76 12.97
S&P Midcap 400
-7.99 14.01 11.37 -4.63 11.21 8.85 10.52
As on 12-Aug-2022
2021
2020
2019
2018
2017
2016
2015
BioMarin Pharmaceutical (BMRN)
0.75 3.71 -0.70 -4.48 7.64 -20.92 15.88
S&P Midcap 400
23.21 11.81 24.05 -12.43 14.45 18.73 -3.71
S&P BSE Sensex
21.99 15.75 14.38 5.87 27.91 1.95 -5.03

Valuation

Stock
Peer Median

Growth & Efficiency

Stock
Peer Median

Solvency

Is there a threat to this company's solvency in the future?

Financial Manipulation

Can creative accounting be detected through the financial numbers?

Peer Comparison

search
search
search
search
    Please wait...

    Valuation Chart

      Please wait...
        Please wait...

        Financials

        Please wait...
        Please wait...
        Please wait...

        Shareholding Pattern

        Other Details

        Chairman & CEO

        Mr. Jean-Jacques Bienaime M.B.A., MBA

        Exec. VP of Fin. & CFO

        Mr. Brian R. Mueller

        Headquarters

        San Rafael, CA
        Edit edit
        Please wait...
        Please wait...

        Key Facts

        • Market cap info

          $17,633.01 Mln

        • Revenue (TTM) info

          $1,911.71 Mln

        • Earnings (TTM) info

          $54.07 Mln

        • Cash info

          $1,109.75 Mln

        • Total Debt info

          $1,081.05 Mln

        • Insider's Holding

          0.57%

        • Liquidity info

          Low

        • 52 Week range info

          $70.73 - 97.76

        • Shares outstanding info

          185,474,000

        • 10 Years Aggregate:

          CFO: $-115.48 Mln

          EBITDA: $-1,016.79 Mln

          Net Profit: $-649.76 Mln

        About The Company

        • Business

          BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.

        • IPO Date

          23-Jul-1999

        • Chairman & CEO

          Mr. Jean-Jacques Bienaime M.B.A., MBA

        • Exec. VP of Fin. & CFO

          Mr. Brian R. Mueller

        • Listing info

          NASDAQ: BMRN

        • Country

          United States

        • Headquarters info

          San Rafael, CA

        • Website info

          https://www.biomarin.com